ONCTERNAL THERAPEUTICS INC - COM (ONCT)

CUSIP: 68236P107

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Equity / COM
Total 13F shares
289,418
Share change
+289,321
Total reported value
$1,923,544
Price per share
$6.65
Number of holders
21
Value change
+$1,922,898
Number of buys
20

Quarterly Holders Quick Answers

What is CUSIP 68236P107?
CUSIP 68236P107 identifies ONCT - ONCTERNAL THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ONCTERNAL THERAPEUTICS INC - COM (ONCT) as of Q2 2019

As of 30 Jun 2019, ONCTERNAL THERAPEUTICS INC - COM (ONCT) was held by 21 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 289,418 shares. The largest 10 holders included Aureus Asset Management, LLC, BlackRock Inc., VANGUARD GROUP INC, BANK OF AMERICA CORP /DE/, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, Bank of New York Mellon Corp, GOLDMAN SACHS GROUP INC, Cohen Capital Management, Inc., and NORTHERN TRUST CORP. This page lists 21 institutional shareholders reporting positions in this security for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.